Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;89:e47

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossi, R.
Right arrow Articles by Di Simplicio, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossi, R.
Right arrow Articles by Di Simplicio, P.
(Circulation Research. 2001;89:e47.)
© 2001 American Heart Association, Inc.


Letters to the Editor

Physiological Levels of S-Nitrosothiols in Human Plasma

Ranieri Rossi, Daniela Giustarini, Aldo Milzani, Roberto Colombo, Isabella Dalle-Donne, Paolo Di Simplicio

Department of Neuroscience, Pharmacology Unit, University of Siena, Siena, Italy, ranieri@unisi.it
Department of Biology, University of Milan, Milan, Italy
Department of Neuroscience, Pharmacology Unit, University of Siena, Siena, Italy

To the Editor:

The hypothesis that endothelial-derived relaxing factor (EDRF) is nitric oxide (NO) has stimulated a wealth of research into the significance of this novel, intriguing molecule. Given its short life, many forms of storage and targeting have been postulated: among these, a pool of derivatives of NO (RSNOs) covalently bound to SH groups of proteins and low molecular weight thiols (eg, glutathione) has been identified in various biological systems. The importance of RSNOs results from the very similar biological actions exhibited by both NO and RSNOs in vivo as well as in vitro.

S-nitroso derivatives of GSH, cysteine, hemoglobin, BSA, and many other protein or nonprotein thiols are potent, fast-acting vasodilators, as well as strong inhibitors of platelet aggregation, like NO itself. Moreover, several nitrosovasodilators, such as nitrosoglycerin, have been reported to function through the formation of S-nitrosothiol intermediates.

S-nitrosothiols in biological samples have been measured by a wide spectrum of different techniques. However, in our opinion, most of these techniques are not devoid of artifacts, and the investigation of endogenous S-nitrosothiol levels, as stated by Neil Hogg, "is hampered by methodological concerns" (page 1482).1 For example, the original report of 7 µmol/L for S-nitrosothiols2 in human plasma has been more recently downgraded to very low levels.3–5

A recent study by Tyurin et al6 showed that the S-nitrosoprotein level (mostly S-nitroso albumin) was 9.2±1.6 µmol/L in normal human plasma and 11.1±2.9 and 9.4±1.5 µmol/L in pregnant and preeclamptic pregnant women, respectively. In particular, these . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. C. Rogers, A. Khalatbari, P. W. Gapper, M. P. Frenneaux, and P. E. James
Detection of Human Red Blood Cell-bound Nitric Oxide
J. Biol. Chem., July 22, 2005; 280(29): 26720 - 26728.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Wang, J. E. Tanus-Santos, C. D. Reiter, A. Dejam, S. Shiva, R. D. Smith, N. Hogg, and M. T. Gladwin
Biological activity of nitric oxide in the plasmatic compartment
PNAS, August 3, 2004; 101(31): 11477 - 11482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Gladwin, X. Wang, C. D. Reiter, B. K. Yang, E. X. Vivas, C. Bonaventura, and A. N. Schechter
S-Nitrosohemoglobin Is Unstable in the Reductive Erythrocyte Environment and Lacks O2/NO-linked Allosteric Function
J. Biol. Chem., July 26, 2002; 277(31): 27818 - 27828.
[Abstract] [Full Text] [PDF]